viernes, 20 de febrero de 2015

UPDATE 1-Sarissa Capital seeks to oust Ariad Pharma CEO

Feb 20 (Reuters) - Sarissa Capital Management LP kicked off a proxy battle with Ariad Pharmaceuticals Inc on Friday, demanding the retirement of Harvey Berger, the drugmaker's chief executive and principal founder.






from Reuters: Company News http://ift.tt/1EdaAIA

via IFTTT

No hay comentarios:

Publicar un comentario